DRIO
NASD DarioHealth Corp.$5.80 ↑ +0.37 (+6.81%) Trading Up from the previous close of $5.43, $0.05 below the day’s high of $5.85
- YTD change
- -49.03%
- vs 20-day SMA
- -11.95%
- vs 200-day SMA
- -30.23%
Price ranges
Price & Performance
-1.67 (-23.52%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.7% away from all-time highs of $1,880.00
- DRIO is down 49% since the beginning of the year
- DRIO is down 63% over the past 12 months
- DRIO is down 12% over the past 1 month
- 1% of all DRIO investors are betting against DRIO
DRIO reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -65.4%.
- Previous minute
- +$0.00
- Last hour
- -$0.01
- Last 5 days
- -5.84%
- vs 8-day SMA
- -5.67%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.